IntroductionPurposeTo evaluate the effect of an intervention on the prevalence and severity of incontinence-associated dermatitis (IAD) in six hospitals in one state in Australia.MethodsThis quasi-experimental pre-and-post study was conducted in 18 wards. Skin and incontinence assessments were conducted on patients during February and March 2020 (pre-intervention) and July and August 2021 (post-intervention). The intervention comprised continence assessment and management tools, a patient education brochure on IAD, the Ghent Global IAD Categorisation Tool (GLOBIAD), and a skin care regime with patient skin protection measures (three-in-one barrier cream cloths, minimisation of bed protection layers, use of appropriate continence pad).ResultsA total of 1897 patients were assessed; 964 in the pre-intervention period and 933 patients in the post-intervention period. Of these, 343 (35.6%) patients in the pre-intervention period and 351 (37.6%) patients in the post-intervention period had incontinence. The prevalence of hospital-acquired IAD was 6.71% in the pre-intervention group and 4.27% in the post-intervention group. Hospital-acquired IAD prevalence reduced by 36.3% (p-value=X) despite higher patient acuity and prevalence of double incontinence in the post-intervention group compared with the pre-intervention group
